Home NDC 53002-1780 ALYACEN 1/35
Product NDC 53002-1780
11-digit product format 530021780
Labeler code 53002
Product ID 53002-1780_543ba0d2-618a-4784-bfa1-0a88cd996b17
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name norethindrone and ethinyl estradiol
Dosage form KIT
Labeler RPK Pharmaceuticals, Inc.
Application ANDA091634
Marketing category ANDA
Marketing start 2012-01-19
Marketing end 0000-00-00
Active strength 0
NDC exclude flag No
Listing certified through 2021-12-31
Current FDA listing Historical FDA.report record Observed NDC auxiliary status history# Observed captured status history: Rows come only from successfully parsed FDA auxiliary ZIP captures. They show the state present in that artifact, not a continuous regulatory timeline. Absence before, after, or between captures is not proof of status, and a known non-data HTTP 403 capture is preserved in backfill provenance but cannot produce a status row.
Historic NDC status page 1 of 1 · 8 matching rows.
Browse every current auxiliary row. · Browse the complete NDC auxiliary source catalog.
Captured / source date, Dataset, Scope table Captured / source date Dataset Scope Product NDC Package NDC Code Status Reporting period Archive Snapshot Source SHA-256 2025-01-20 13:05 UTC · source 2025-01-20 excluded product product 53002-1780 U Excluded because listing certification expired excluded / ndc_excluded.zip ed331223b511…672a5bd82f5f…2025-01-20 13:05 UTC · source 2025-01-20 excluded package package 53002-1780 53002-1780-6 U Excluded because listing certification expired excluded / ndc_excluded.zip ed331223b511…672a5bd82f5f…2025-01-20 13:05 UTC · source 2025-01-20 excluded package package 53002-1780 53002-1780-3 U Excluded because listing certification expired excluded / ndc_excluded.zip ed331223b511…672a5bd82f5f…2025-01-20 13:05 UTC · source 2025-01-20 excluded package package 53002-1780 53002-1780-1 U Excluded because listing certification expired excluded / ndc_excluded.zip ed331223b511…672a5bd82f5f…2025-01-11 03:41 UTC · source 2025-01-10 excluded product product 53002-1780 U Excluded because listing certification expired excluded / ndc_excluded.zip 0efc9e666f02…f202fb6c5f17…2025-01-11 03:41 UTC · source 2025-01-10 excluded package package 53002-1780 53002-1780-6 U Excluded because listing certification expired excluded / ndc_excluded.zip 0efc9e666f02…f202fb6c5f17…2025-01-11 03:41 UTC · source 2025-01-10 excluded package package 53002-1780 53002-1780-3 U Excluded because listing certification expired excluded / ndc_excluded.zip 0efc9e666f02…f202fb6c5f17…2025-01-11 03:41 UTC · source 2025-01-10 excluded package package 53002-1780 53002-1780-1 U Excluded because listing certification expired excluded / ndc_excluded.zip 0efc9e666f02…f202fb6c5f17…
Source provenance: Browse the complete Orange Book source catalog · source snapshot 1 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A091634-001 ALYACEN 1/35 ETHINYL ESTRADIOL; NORETHINDRONE 0.035MG;1MG TABLET / ORAL-28 AB 2012-01-19
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 1 matching rows.
Application-product, TE code table Application-product TE code A091634-001 AB
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 2 · 41 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-02-19 14:30 UTC 2026-02 A091634-001 ALYACEN 1/35 0.035MG;1MG TABLET / ORAL-28 AB 2012-01-19 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A091634-001 ALYACEN 1/35 0.035MG;1MG TABLET / ORAL-28 AB 2012-01-19 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 A091634-001 ALYACEN 1/35 0.035MG;1MG TABLET / ORAL-28 AB 2012-01-19 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A091634-001 ALYACEN 1/35 0.035MG;1MG TABLET / ORAL-28 AB 2012-01-19 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A091634-001 ALYACEN 1/35 0.035MG;1MG TABLET / ORAL-28 AB 2012-01-19 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A091634-001 ALYACEN 1/35 0.035MG;1MG TABLET / ORAL-28 AB 2012-01-19 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A091634-001 ALYACEN 1/35 0.035MG;1MG TABLET / ORAL-28 AB 2012-01-19 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A091634-001 ALYACEN 1/35 0.035MG;1MG TABLET / ORAL-28 AB 2012-01-19 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A091634-001 ALYACEN 1/35 0.035MG;1MG TABLET / ORAL-28 AB 2012-01-19 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 A091634-001 ALYACEN 1/35 0.035MG;1MG TABLET / ORAL-28 AB 2012-01-19 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A091634-001 ALYACEN 1/35 0.035MG;1MG TABLET / ORAL-28 AB 2012-01-19 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 A091634-001 ALYACEN 1/35 0.035MG;1MG TABLET / ORAL-28 AB 2012-01-19 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 A091634-001 ALYACEN 1/35 0.035MG;1MG TABLET / ORAL-28 AB 2012-01-19 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 A091634-001 ALYACEN 1/35 0.035MG;1MG TABLET / ORAL-28 AB 2012-01-19 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 A091634-001 ALYACEN 1/35 0.035MG;1MG TABLET / ORAL-28 AB 2012-01-19 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 A091634-001 ALYACEN 1/35 0.035MG;1MG TABLET / ORAL-28 AB 2012-01-19 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 A091634-001 ALYACEN 1/35 0.035MG;1MG TABLET / ORAL-28 AB 2012-01-19 4b0b4de00fa7…2019-12-13 00:20 UTC 2019-12 A091634-001 ALYACEN 1/35 0.035MG;1MG TABLET / ORAL-28 AB 2012-01-19 74a2ff9319b5…2022-03-09 01:35 UTC 2022-03 A091634-001 ALYACEN 1/35 0.035MG;1MG TABLET / ORAL-28 AB 2012-01-19 bb7c543d1eb4…2021-12-28 21:50 UTC 2021-12 A091634-001 ALYACEN 1/35 0.035MG;1MG TABLET / ORAL-28 AB 2012-01-19 782e0a99824c…2021-05-05 16:15 UTC · 3 captures of this ZIP 2021-05 A091634-001 ALYACEN 1/35 0.035MG;1MG TABLET / ORAL-28 AB 2012-01-19 87673890dc5c…2021-03-12 10:30 UTC 2021-03 A091634-001 ALYACEN 1/35 0.035MG;1MG TABLET / ORAL-28 AB 2012-01-19 5aa47cf7b7d7…2020-12-22 03:56 UTC 2020-12 A091634-001 ALYACEN 1/35 0.035MG;1MG TABLET / ORAL-28 AB 2012-01-19 8869cabd3fbd…2020-11-12 02:37 UTC 2020-11 A091634-001 ALYACEN 1/35 0.035MG;1MG TABLET / ORAL-28 AB 2012-01-19 c0c555d07b60…2019-12-14 00:12 UTC 2019-12 A091634-001 ALYACEN 1/35 0.035MG;1MG TABLET / ORAL-28 AB 2012-01-19 3f01610625f2…2019-09-15 20:21 UTC 2019-09 A091634-001 ALYACEN 1/35 0.035MG;1MG TABLET / ORAL-28 AB 2012-01-19 b00525d2431f…2019-07-19 19:46 UTC 2019-07 A091634-001 ALYACEN 1/35 0.035MG;1MG TABLET / ORAL-28 AB 2012-01-19 ea99ee380514…2024-03-16 18:09 UTC · 4 captures of this ZIP 2024-03 A091634-001 ALYACEN 1/35 0.035MG;1MG TABLET / ORAL-28 AB 2012-01-19 6a51e52b5d6a…2024-02-18 07:12 UTC 2024-02 A091634-001 ALYACEN 1/35 0.035MG;1MG TABLET / ORAL-28 AB 2012-01-19 1c564ffb4f44…2023-12-20 04:57 UTC 2023-12 A091634-001 ALYACEN 1/35 0.035MG;1MG TABLET / ORAL-28 AB 2012-01-19 ea1830bbd6c7…2023-11-28 05:40 UTC · 2 captures of this ZIP 2023-11 A091634-001 ALYACEN 1/35 0.035MG;1MG TABLET / ORAL-28 AB 2012-01-19 a72a2bbeb626…2023-10-25 00:34 UTC · 2 captures of this ZIP 2023-10 A091634-001 ALYACEN 1/35 0.035MG;1MG TABLET / ORAL-28 AB 2012-01-19 9b2671bbb829…2023-07-15 15:27 UTC · 2 captures of this ZIP 2023-07 A091634-001 ALYACEN 1/35 0.035MG;1MG TABLET / ORAL-28 AB 2012-01-19 a67488948f0b…2023-06-13 01:57 UTC · 3 captures of this ZIP 2023-06 A091634-001 ALYACEN 1/35 0.035MG;1MG TABLET / ORAL-28 AB 2012-01-19 3f0d92c62455…2023-05-13 08:27 UTC 2023-05 A091634-001 ALYACEN 1/35 0.035MG;1MG TABLET / ORAL-28 AB 2012-01-19 053a50430f4f…2023-01-26 05:58 UTC 2023-01 A091634-001 ALYACEN 1/35 0.035MG;1MG TABLET / ORAL-28 AB 2012-01-19 3bdfa0b2c4d7…2022-11-12 20:34 UTC · 5 captures of this ZIP 2022-11 A091634-001 ALYACEN 1/35 0.035MG;1MG TABLET / ORAL-28 AB 2012-01-19 3a93d1ddd44b…2022-10-28 04:53 UTC 2022-10 A091634-001 ALYACEN 1/35 0.035MG;1MG TABLET / ORAL-28 AB 2012-01-19 f41ea6bd6efb…2022-09-29 23:25 UTC 2022-09 A091634-001 ALYACEN 1/35 0.035MG;1MG TABLET / ORAL-28 AB 2012-01-19 e64feba35796…2022-07-09 03:26 UTC · 3 captures of this ZIP 2022-07 A091634-001 ALYACEN 1/35 0.035MG;1MG TABLET / ORAL-28 AB 2012-01-19 cb3db0bc1861…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 2 · 41 observed states.
openFDA label cross-check# Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
Matched openFDA labels page 1 of 1 · 3 matching rows.
DailyMed Product Concepts# FDA-Initiated Inactive NDC Indexing# NDC, Effective, Action table NDC Effective Action Document Indexing SPL Related label 53002-1780-1 2025-01-30 C162847 48780-1 f386c64a-4529-0266-e053-dadaa90a7c1a ALYACEN 7/7/7 (Norethindrone and Ethinyl Estradiol Tablets USP, 0.5 mg/0.035 mg, 0.75 mg/0.035 mg, 1 mg/0.035 mg) ALYACEN 1/35 (Norethindrone and Ethinyl Estradiol Tablets USP, 1 mg/0.035 mg) 53002-1780-3 2025-01-30 C162847 48780-1 f386c64a-4529-0266-e053-dadaa90a7c1a ALYACEN 7/7/7 (Norethindrone and Ethinyl Estradiol Tablets USP, 0.5 mg/0.035 mg, 0.75 mg/0.035 mg, 1 mg/0.035 mg) ALYACEN 1/35 (Norethindrone and Ethinyl Estradiol Tablets USP, 1 mg/0.035 mg) 53002-1780-6 2025-01-30 C162847 48780-1 f386c64a-4529-0266-e053-dadaa90a7c1a ALYACEN 7/7/7 (Norethindrone and Ethinyl Estradiol Tablets USP, 0.5 mg/0.035 mg, 0.75 mg/0.035 mg, 1 mg/0.035 mg) ALYACEN 1/35 (Norethindrone and Ethinyl Estradiol Tablets USP, 1 mg/0.035 mg) 53002-1780-1 2023-06-07 C162847 48780-1 f386c64a-4529-0266-e053-dadaa90a7c1a ALYACEN 7/7/7 (Norethindrone and Ethinyl Estradiol Tablets USP, 0.5 mg/0.035 mg, 0.75 mg/0.035 mg, 1 mg/0.035 mg) ALYACEN 1/35 (Norethindrone and Ethinyl Estradiol Tablets USP, 1 mg/0.035 mg) 53002-1780-3 2023-06-07 C162847 48780-1 f386c64a-4529-0266-e053-dadaa90a7c1a ALYACEN 7/7/7 (Norethindrone and Ethinyl Estradiol Tablets USP, 0.5 mg/0.035 mg, 0.75 mg/0.035 mg, 1 mg/0.035 mg) ALYACEN 1/35 (Norethindrone and Ethinyl Estradiol Tablets USP, 1 mg/0.035 mg) 53002-1780-6 2023-06-07 C162847 48780-1 f386c64a-4529-0266-e053-dadaa90a7c1a ALYACEN 7/7/7 (Norethindrone and Ethinyl Estradiol Tablets USP, 0.5 mg/0.035 mg, 0.75 mg/0.035 mg, 1 mg/0.035 mg) ALYACEN 1/35 (Norethindrone and Ethinyl Estradiol Tablets USP, 1 mg/0.035 mg) 53002-1780-1 2023-01-30 C162847 48780-1 f386c64a-4529-0266-e053-dadaa90a7c1a ALYACEN 7/7/7 (Norethindrone and Ethinyl Estradiol Tablets USP, 0.5 mg/0.035 mg, 0.75 mg/0.035 mg, 1 mg/0.035 mg) ALYACEN 1/35 (Norethindrone and Ethinyl Estradiol Tablets USP, 1 mg/0.035 mg) 53002-1780-3 2023-01-30 C162847 48780-1 f386c64a-4529-0266-e053-dadaa90a7c1a ALYACEN 7/7/7 (Norethindrone and Ethinyl Estradiol Tablets USP, 0.5 mg/0.035 mg, 0.75 mg/0.035 mg, 1 mg/0.035 mg) ALYACEN 1/35 (Norethindrone and Ethinyl Estradiol Tablets USP, 1 mg/0.035 mg) 53002-1780-6 2023-01-30 C162847 48780-1 f386c64a-4529-0266-e053-dadaa90a7c1a ALYACEN 7/7/7 (Norethindrone and Ethinyl Estradiol Tablets USP, 0.5 mg/0.035 mg, 0.75 mg/0.035 mg, 1 mg/0.035 mg) ALYACEN 1/35 (Norethindrone and Ethinyl Estradiol Tablets USP, 1 mg/0.035 mg)
DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 53002-1780-1 ALYACEN 1/35 1 in 1 BLISTER PACK KIT 1 4 53002-1780-3 ALYACEN 1/35 1 in 1 BLISTER PACK KIT 1 4 53002-1780-3 ALYACEN 1/35 3 in 1 POUCH KIT 3 4 53002-1780-6 ALYACEN 1/35 6 in 1 POUCH KIT 6 4 53002-1780-6 ALYACEN 1/35 1 in 1 BLISTER PACK KIT 1 4
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 53002-1780 ALYACEN 1/35 (NORETHINDRONE AND ETHINYL ESTRADIOL) KIT [RPK PHARMACEUTICALS, INC.] 4 Legacy NDC, 5 package rows 20230609_5c4c8517-b81a-4716-be70-1b2b7e7dd146.zip
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Marketing end Sample Exclude flag Status 53002-1780-1 53002178001 1 KIT in 1 BLISTER PACK (53002-1780-1) 1 kit 2019-01-01 0000-00-00 No No Current 53002-1780-3 53002178003 3 BLISTER PACK in 1 POUCH (53002-1780-3) > 1 KIT in 1 BLISTER PACK 3 blister pack 2019-01-01 0000-00-00 No No Current 53002-1780-6 53002178006 6 BLISTER PACK in 1 POUCH (53002-1780-6) > 1 KIT in 1 BLISTER PACK 6 blister pack 2019-01-01 0000-00-00 No No Current